BioCardia Updates on FDA Helix and PMDA CardiAMP Submission Timelines
BioCardia updated on its regulatory submission timelines, noting a Q4 2026 PMDA Shonin application and a Q4 2026 De Novo pre-submission for its Helix platform.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed